Weight loss injections may alter taste and smell
A study published in the journal JAMA Otolaryngology revealed that weight loss and diabetes medications from the GLP-1 receptor agonist class, such as Ozempic and Mounjaro, may be associated with an increased likelihood of taste and smell disturbances by up to 50%. The findings suggest that the effects of these drugs extend to neural pathways involved in taste and smell perception, with approximately 20% of users reporting increased sweetness or saltiness of foods, although such side effects remain generally rare. Experts emphasized that appetite loss and taste changes are not the sole factors in weight loss; other factors such as diet and physical activity continue to be important for achieving sustainable health outcomes.
Notice: This Is an AI-Generated Summary
Comments (0)